CLINICAL / SCIENTIFIC PRESENTATION AND PUBLICATION HIGHLIGHTS

The information contained in each post on this page was factually accurate on the date it was issued and posted. 

STRO-001 – Publication Highlights

Pan Pacific Lymphoma, 2018 HIGH FREQUENCY OF CD74 EXPRESSION IN B-CELL NON-HODGKIN’S LYMPHOMA (NHL) AND TARGETING WITH STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC) WITH POTENT IN VITROCYTOTOXICTY AND IN VIVOANTI-TUMOR ACTIVITY A Yu1, C Abrahams1, M...

read more

Science and Platform Publication Highlights

Biotechnol Bioeng. 2011 Jul;108(7):1570-8. doi: 10.1002/bit.23103. Epub 2011 Mar 31. Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines. Zawada JF, Yin G, Steiner AR, Yang J,...

read more

World ADC Summit 2013 – Dual-Warhead Antibody Drug Conjugate

SAN FRANCISCO, Oct. 15, 2013 - Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis technology, presented today the first data involving a dual-warhead antibody drug conjugate...

read more
Sutro Biopharma, Inc.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.